MissionIR Articles
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) CEO Discusses Strategic Business Models, Nascent Stage of B2C Platform
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, showcased its powerful capabilities during a recent virtual investor summit. Trxade Group’s CEO Suren Ajjarapu presented for the company to discuss the platform, which…
-
Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure
The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Spotlight on Dynamic Platform Capabilities
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s…
-
Trxade Group Inc. (NASDAQ: MEDS) Pharmaceutical Supply Chain Trading Platform Gives Independent Drugstores a New Lease on Life
Pressing need for efficient drug procurement, delivery as costs rise Trxade platform speeds up delivery, cuts costs Such efficiencies crucial to keeping America’s independent pharmacies alive Around half of 24,000 independent pharmacies have already signed…
-
Trxade Group, Inc. (NASDAQ: MEDS) Showcases Prescription Affordability Efforts During Virtual Investor Summit
Pharmaceutical industry services provider Trxade Group Inc. presented an overview of the company’s structure and strategy at this month’s LD 500 invitational microcap investor summit The investor summit was a virtual gathering place during the…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Offers ‘Radical Price Transparency’ to Maximize Savings, Lower Costs of Pharmaceuticals
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, has achieved a growing distinction and web-based presence, offering transparency in pharmaceutical purchasing. The company’s flagship Bonum+ platform provides subscribers with access to drug…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Present at September Virtual Investor Conferences
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, on Thursday announced that it will participate in the following virtual investor conferences during the month of September 2020: the Colliers Institutional Investor…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Delivers Crucial PPE, Drives Increased Revenues in Q2 2020
Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, achieved a record $6.6 million in revenues for the second quarter of 2020, representing a 244% increase compared to the same period last year.…
-
Trxade Group, Inc. (NASDAQ: MEDS) to Boost Brand Through Participation in LD 500 Virtual Investor Conference
Trxade Group Inc. is a supplies and services innovator for the pharmaceutical industry, working to keep small retailers competitive with large chains and costs accessible for end-use patients Trxade Group has seen its brand grow…
-
Trxade Group, Inc. (NASDAQ: MEDS) Augments B2B Services with New Bundled, COVID-responsive Employee Wellness Package
Pharmaceutical supplies and services innovator Trxade Group Inc. has announced a new B2B resource that bundles telemedicine services that may prove particularly useful for companies during the ongoing pandemic period Trxade Group’s new Bonum+ platform…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Present at LD Micro 500 Virtual Investor Conference
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, today announced that management will present at the LD 500 virtual investor conference, hosted by LD Micro and taking place from September 1…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Model Gaining Ground Amid Increased Demand
Trxade Group (NASDAQ: MEDS) has continued to offer innovative medical consultation and prescription drug solutions and was answering today’s health care demands well ahead of COVID-19. Even before emergence of the pandemic, Trxade Group was…
-
Trxade Group, Inc. (NASDAQ: MEDS) to Present at LD Micro’s LD 500 Virtual Conference
The exclusively online LD 500 event is expected to gather more than 300 companies and 20,000 attendees in early September Trxade reported record revenue in Q2 2020 and expects a strong second half of the…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Launches First-of-Its-Kind B2B Platform
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform,has unveiled Bonum+, a business-to-business platform that bundles telehealth, a COVID-19 risk assessment tool and a Personal Protective Equipment (“PPE”) purchasing tool together. Available through…
-
Trxade Group, Inc. (NASDAQ: MEDS) Continues to Report Revenue Successes Despite Pandemic’s Economic Ravages
Trxade Group provides a digitalized supply stream for pharmaceutical and health care services as part of its founding focus on empowering small, independent pharmacies that historically have struggled to compete against large corporate chains The…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Keeps Telehealth Patients in-the-Know with Timely Educational Resources
Trxade Group (NASDAQ: MEDS) recently expanded Bonum Health, its patient-empowerment telehealth platform, to add access to educational resources to assist its users with better understanding and tools to direct their care management. The secure, privacy-enabled…
-
Trxade Group, Inc. (NASDAQ: MEDS) Reports Record 244% YoY Revenue Growth in Q2 2020
As the spread of the novel coronavirus unexpectedly reached pandemic proportions, Trxade Group stepped in to help patients and providers continue to access resources and PPE products through a virtual environment that is safe from…
-
MissionIRNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Announces Record Financial Results for Q2 2020
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, on Monday provided its financial results for the second quarter ended June 30, 2020. Among the highlights, Trxade reported record revenues and an…
-
Trxade Group Inc. (NASDAQ: MEDS) To Present 2nd Quarter Financial Report Amid Pandemic-driven Growth in Telehealth Services
Pharmaceutical and health care services company Trxade Group Inc. is enjoying growing attention as it continues to roll out remote-access medical solutions that are suited to the ongoing COVID-19 pandemic and the need to prevent…
-
MissionIRNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Corporate Presentation Highlights Milestones, Growing Popularity of Platform
Trxade Group (NASDAQ: MEDS) recently released a corporate presentation that highlights the company’s major milestones, increased revenues and earnings, and the growing popularity of its pharmaceutical platform (http://ibn.fm/4F16k). An article that discusses the presentation, as…
Search Articles
Latest Articles
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Marks Pivotal Moment on Path to 2026 Rare Earth Oxide Production
- PowerBank Corporation (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: 103) Marks Bold Entry Into the Growing Battery Storage Market with 4.99 MW BESS in Ontario
- Soligenix Inc. (NASDAQ: SNGX) Working to Advance Heat-Stable Ricin Vaccine with Promising Efficacy
- New Pacific Metals Corp. (NYSE American: NEWP) (TSX: NUAG) Eyes Bolivia’s Untapped Silver Potential Amid Global Supply Gaps
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Reports Q2 2025 Results, Advances TPI 287 Toward Phase 2 GBM Trial